RemeGen Co., Ltd. (the “Company”) released its monthly return for the period ended 31 October 2025. The total authorized/registered share capital remained at RMB 563,608,243, comprising 208,581,239 H shares listed on The Stock Exchange of Hong Kong Limited (stock code: 09995) and 355,027,004 A shares listed on the Shanghai Stock Exchange (stock code: 688331).

During October 2025, no increase or decrease was recorded in the issued ordinary H shares or ordinary A shares, with both share classes maintaining their month-end balance. The Company also reported details related to its 2022 and 2023 A Share Incentive Schemes, indicating potential new share issuances in the future. However, no new shares were issued or treasury shares transferred during the reporting period.